Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities
Net income	$ 262,934	$ 317,367
Adjustments to reconcile net income to net cash used in operating activities
Interest income and dividend income earned in cash and investment held in Trust Account	(985,835)	(2,313,587)
Non-redemption agreement expense		452,026
Change in operating assets and liabilities:
(Increase) decrease in prepaid expenses	(20,250)	144,405
(Decrease) increase in accrued liabilities	(17,455)	109,958
(Decrease) increase in income tax payable	(76,832)	475,268
Net cash used in operating activities	(837,438)	(814,563)
Cash flows from investing activities
Cash withdrawn from Trust Account in connection to redemption	19,036,950	60,411,251
Cash withdrawn from Trust Account		419,279
Extension payments deposited in Trust Account	(700,000)	(100,000)
Net cash provided by investing activities	18,336,950	60,730,530
Cash flows from financing activities
Redemption of common stock	(19,036,950)	(60,411,251)
Proceed from promissory note – related party	1,400,000
Advance from a related party	88,293	71,639
Net cash used in financing activities	(17,548,657)	(60,339,612)
NET CHANGE IN CASH	(49,145)	(423,645)
Cash, beginning of period	60,440	680,812
Cash, end of period	11,295	257,167
Reconciliation to amounts on unaudited condensed consolidated balance sheets:
Cash	11,295	132,080
Cash in escrow		125,087
Reconciliation to amount	11,295	257,167
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:
Accretion of carrying value to redemption value	(1,685,835)	(1,994,659)
Excise tax payable attributable to redemption of common stock	$ 190,370	$ 765,515